<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Adv Ther</journal-id><journal-id journal-id-type="iso-abbrev">Adv Ther</journal-id><journal-title-group><journal-title>Advances in Therapy</journal-title></journal-title-group><issn pub-type="ppub">0741-238X</issn><issn pub-type="epub">1865-8652</issn><publisher><publisher-name>Springer Healthcare</publisher-name><publisher-loc>Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4079522</article-id><article-id pub-id-type="publisher-id">103</article-id><article-id pub-id-type="doi">10.1007/s12325-014-0103-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ginsberg</surname><given-names>David</given-names></name><address><email>ginsberg@ccnt.usc.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Cruz</surname><given-names>Francisco</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Herschorn</surname><given-names>Sender</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Gousse</surname><given-names>Angelo</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Keppenne</surname><given-names>V&#x000e9;ronique</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Aliotta</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Sievert</surname><given-names>Karl-Dietrich</given-names></name><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Brin</surname><given-names>Mitchell F.</given-names></name><xref ref-type="aff" rid="Aff8"/><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Jenkins</surname><given-names>Brenda</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Lam</surname><given-names>Wayne</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>Heesakkers</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff11"/></contrib><contrib contrib-type="author"><name><surname>Haag-Molkenteller</surname><given-names>Cornelia</given-names></name><xref ref-type="aff" rid="Aff8"/></contrib><aff id="Aff1"><label/>Department of Urology, University of Southern California Institute of Urology, 1441 Eastlake Avenue, NOR 7416, Los Angeles, CA 90033-9178 USA </aff><aff id="Aff2"><label/>Faculty of Medicine do Porto, Hospital S&#x000e3;o Jo&#x000e3;o, IBMC, Porto, Portugal </aff><aff id="Aff3"><label/>University of Toronto, Toronto, Canada </aff><aff id="Aff4"><label/>Memorial Hospital Miramar, Miramar, FL USA </aff><aff id="Aff5"><label/>Universit&#x000e9; de Li&#x000e8;ge, Li&#x000e8;ge, Belgium </aff><aff id="Aff6"><label/>Western New York Urology Associates, Cheektowaga, NY USA </aff><aff id="Aff7"><label/>University of T&#x000fc;bingen, T&#x000fc;bingen, Germany </aff><aff id="Aff8"><label/>Allergan, Inc., Irvine, CA USA </aff><aff id="Aff9"><label/>Department of Neurology, University of California, Irvine, CA USA </aff><aff id="Aff10"><label/>Allergan Ltd, Marlow, Buckinghamshire, UK </aff><aff id="Aff11"><label/>Radboud Universiteit, Nijmegen, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>2</month><year>2014</year></pub-date><pub-date pub-type="ppub"><year>2014</year></pub-date><volume>31</volume><issue>2</issue><fpage>242</fpage><lpage>242</lpage><permissions><copyright-statement>&#x000a9; Springer Healthcare 2014</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d30e91" ext-link-type="doi" xlink:href="10.1007/s12325-013-0054-z"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Healthcare 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum to: Adv Ther (2013) 30:819&#x02013;833 DOI 10.1007/s12325-013-0054-z</title><p>The authors would like to make the following correction to the above mentioned article. The title should be changed from &#x0201c;OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor <underline>Activity</underline> Regardless of Concomitant Anticholinergic Use or Neurologic Etiology&#x0201d; to &#x0201c;OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor <underline>Overactivity</underline> Regardless of Concomitant Anticholinergic Use or Neurologic Etiology&#x0201d;.</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1007/s12325-013-0054-z.</p></fn></fn-group></back></article>